Optimi Health is trading 5.88% up at $5.04, but no clear company-specific announcement dated September 15, 2026, explains the move.
- The stock is extending its second consecutive advancing session.
- Recent coverage centers on the September 10 Health Canada-authorized Phase 2 trial announcement and the September 14β16 H.C. Wainwright conference; neither is explicitly linked to todayβs trading.
- Broader markets and biotech are declining, so the catalyst remains unclear.